SEC Form 4 · accession 0001128732-16-000030
Sunshine Biopharma Inc. · SBFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve N. Slilaty
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Oct 10, 2016
Accepted (ET)
Nov 7, 2016 · 11:41 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001402328
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 10, 2016 | J | 136,861,968 | $0.00 | D | 215,014,224 | I | Owned by Advanomics Corporation, an entity controlled by Reporting Person. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1136,861,968 shares owned by Advanomics Corporation, an entity controlled by Reporting Person, were disposed of pursuant to a share exchange with an unrelated party; no consideration was received as a result of the share exchange.